CenterWatch: Clinical Trials in Category (390) Metastatic Cancer

The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Clinical Trials

Bookmark | Print | E-Mail

Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology

Metastatic Cancer

State

California
Florida
Georgia
Illinois
Kentucky
Massachusetts
Michigan
New York
Ohio

Country

[X] Australia
[X] Austria
[X] Belgium
[X] Finland
[X] France
[X] Germany
[X] Italy
[X] Korea
[X] Lithuania
[X] Norway
[X] Peru
[X] Poland
[X] Portugal
[X] Russian Federation
[X] Spain
[X] Sweden
[X] Taiwan
[X] United Kingdom

California

Duarte : City of Hope

PHII-80 PHL-051 NCI #7502: A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas

Santa Monica : Premiere Oncology

A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors

Santa Monica : Premiere Oncology

A Phase I Study of Single Agent LY2584702 in Patients with Advanced or Metastatic Cancer

Florida

Aventura : South Florida Medical Research

Phase II, Clinical Trial For Patients with Prostate Cancer or Breast Cancer with Metastatic Disease

Gainesville : Gainesville Hematology/ Oncology Associates

A Randomized Phase III Trial of Cetuximab, Bevacizumab and Biweekly Infusional 5-FU/Leucovorin (FOLF-CB) versus Oxaliplatin, Bevacizumab, and Biweekly Infusional 5-FU/Leucovorin (Bev-FOLFOX) in First-line Treatment of Metastatic Colorectal Cancer

Gainesville : Gainesville Hematology/ Oncology Associates

A Randomized, Phase 2B Study of Sunitinib Plus Oxaliplatin, 5-FU, and Leucovorin (FOLFOX)versus Bevacizumab Plus FOLFOX as First-line Treatment in Patients with Metastatic Colorectal Cancer

Georgia

Savannah : Memorial Health University Medical Center New!

Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone SWOG S0622

Illinois

Centralia : Southern Illinois Hematology/Oncology

This is a Phase 2 study to evaluate the efficacy and safety of NKTR-102 (a pegylated Irinotecan) in patients with breast cancer.

Kentucky

Louisville : Norton Health Care

This is a Phase 2 study to evaluate the efficacy and safety of NKTR-102 (a pegylated Irinotecan) in patients with breast cancer.

Massachusetts

Boston : Massachusetts General Hospital Cancer Center

An open-label dose escalation study of patients with solid tumors treated with STA-9090

Boston : Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center

An open-label dose escalation study of patients with solid tumors treated with STA-9090

Boston : Dana Farber Cancer Institute

An open-label dose escalation study of patients with solid tumors treated with STA-9090

Michigan

Detroit : Karmanos Cancer Institute Wayne State University

An open-label dose escalation study of patients with solid tumors treated with STA-9090

New York

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research

A Pilot Feasibility Study of a Low Carbohydrate Diet In patients with Advanced Cancer. {Also known as the RECHARGE Trial (REduced CarboHydrates Against REsistant Growth Tumors).}

Manhasset : Biomedical Research Alliance of New York

Metastatic Cancer to the Brain - Adults

Ohio

Kettering : US Oncology Dayton Oncology and Hematology, P.A.

A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors

Australia

BEDFORD PARK, SA : Research Site